Cumulative preferreds offer a compelling solution for income-focused investors, especially in uncertain and challenging ...
Citigroup Inc. (NYSE:C), a financial giant with a market capitalization of $152 billion, has announced the creation of a new ...
Cherry Hill Mortgage Investment shows short-term momentum but risks persist. Read why CHMI stock's high yield could signal ...
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...
Motley Fool Stock Advisor offers investment guidance for beginners and is best for long-term focused, self-directed investors who want to take advantage of expert stock recommendations.
an open active or automated investing account. Promotion: Get up to $1,000 in stock when you fund a new account. App store rating: 4.8 iOS/3.8 Android Consider it if: You want an easy-to-use ...
Trevor Walsh is an analyst at JMP Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future ...
CRISPR Therapeutics (NASDAQ:CRSP) received an upgrade in its stock rating by analysts at TD Cowen, changing from Sell to Hold, while maintaining a price target of $35.00. The revision in the rating ...
JPMorgan Chase & Co. Dep. Pfd. (Rep. 1/400th Pfd. Series EE) JPM.PRC 2.42% Allstate Corp. Dep. Pfd. (Rep. 1/1000th Perp. Pfd. Series H) ALL.PRH 2.29% JPMorgan Chase ...
Rajat Gupta is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth ...
Despite a comprehensive loss in Q4, Two Harbors Investment Corp (TWO) showcases resilience with strategic shifts and a promising economic return for 2024. While the top- and bottom-line numbers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results